AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23415907 — intervention group
Group type: EXPERIMENTAL
Intervention: Total glucosides of paeony (TGP)
Number of subjects: 204
Study 21194310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean women with PCOS (BMI <25 kg/m²)
Number of subjects: 78
Study 21194310 — intervention group
Group type: COMPARATOR
Intervention: Nonlean subjects (BMI ≥28 kg/m²)
Number of subjects: 78
Study 21194310 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 78
Study 19875763 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention (6-month, 14-session)
Number of subjects: 150
Study 19875763 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 17061632 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine 2 mg/kg with clonidine 2 microg/kg (group BUP+CLO)
Number of subjects: 30
Study 17061632 — intervention group
Group type: COMPARATOR
Intervention: 0.125% bupivacaine 2 mg/kg (group BUP)
Number of subjects: 30
Study 14722164 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10
Study 14722164 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide
Number of subjects: 10
Study 11499408 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of 3 amino-acid substitutions (His275Gln, Gly281Ala, His299Gln) and kappa repeat region
Number of subjects: 53
Study 11499408 — intervention group
Group type: EXPERIMENTAL
Intervention: cg2 gene mutations
Number of subjects: 53
Study 11499408 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 codons and kappa repeat region
Number of subjects: 53
Study 11499408 — intervention group
Group type: EXPERIMENTAL
Intervention: kappa repeat region
Number of subjects: 53
Study 9710396 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane in 66% nitrous oxide
Number of subjects: 51
Study 9710396 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane in oxygen
Number of subjects: 51
Study 9710396 — intervention group
Group type: COMPARATOR
Intervention: 5% halothane in 66% nitrous oxide
Number of subjects: 51
Study 9710396 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 51
Study 8273728 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg daily)
Number of subjects: 58
Study 8273728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 2915010 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 50
Study 2915010 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and plaster
Number of subjects: 50
Study 773180 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin
Number of subjects: 49
Study 773180 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin plus gentamicin
Number of subjects: 49
Study 773180 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin plus gentamicin
Number of subjects: 49
Study 773180 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 49
Study 773180 — intervention group
Group type: COMPARATOR
Intervention: Single antibiotic therapy
Number of subjects: 49
Study 773180 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 49
Study 31786218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitinol stents
Number of subjects: 110
Study 31786218 — intervention group
Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 110
Study 28791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Apathy present (measured using the Apathy Evaluation Scale - AES-10)
Number of subjects: 713
Study 28791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Apathy present (controlled for depressive symptoms)
Number of subjects: 713
Study 28791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Apathy as a dimensional construct (1 standard deviation increase in AES-10 scores)
Number of subjects: 713
Study 28791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 713
Study 28791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age in years
Number of subjects: 713
Study 25580665 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin detemir
Number of subjects: 11
Study 25580665 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 11
Study 23317685 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone film
Number of subjects: 92
Study 23317685 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine-naloxone tablets
Number of subjects: 92
Study 21275531 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level, dual-wavelength laser and massage device
Number of subjects: 83
Study 21275531 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated contralateral thigh)
Number of subjects: 83
Study 19006538 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol + prazosin
Number of subjects: 59
Study 19006538 — intervention group
Group type: COMPARATOR
Intervention: Nadolol + ligation
Number of subjects: 59
Study 16951997 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (1 mg/kg intravenously over 2.5 min)
Number of subjects: 104
Study 16951997 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (additional 0.33 mg/kg if pain relief was inadequate)
Number of subjects: 104
Study 15532659 — intervention group
Group type: EXPERIMENTAL
Intervention: Masker cue preceding a yes/no trial interval
Number of subjects: 0
Study 15532659 — intervention group
Group type: COMPARATOR
Intervention: Random frequency signal detection
Number of subjects: 0
Study 11502949 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care (intervention) for uninsured patients
Number of subjects: 383
Study 11502949 — intervention group
Group type: COMPARATOR
Intervention: Usual care for uninsured patients (control)
Number of subjects: 383
Study 11502949 — intervention group
Group type: COMPARATOR
Intervention: Usual care for insured patients (control)
Number of subjects: 383
Study 11502949 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care for insured patients
Number of subjects: 383
Study 9236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum pentosidine levels in RA patients
Number of subjects: 77
Study 9236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary pentosidine levels in RA patients
Number of subjects: 77
Study 9236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosidine levels in active RA patients
Number of subjects: 77
Study 9236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of pentosidine with clinical features
Number of subjects: 77
Study 9236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum and urinary pentosidine levels
Number of subjects: 77
Study 10137016 — intervention group
Group type: EXPERIMENTAL
Intervention: Likert‐type scale form (1 = Strongly Agree, 5 = Strongly Disagree)
Number of subjects: 159
Study 10137016 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed scale form (1 = Very Satisfied, 5 = Very Dissatisfied)
Number of subjects: 159
Study 10137016 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectational scale form (1 = More Than I Expected, 5 = Less Than I Expected)
Number of subjects: 159
Study 3299618 — intervention group
Group type: EXPERIMENTAL
Intervention: Antilymphocyte serum, azathioprine, and prednisone
Number of subjects: 45
Study 3299618 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine and prednisone only (Control)
Number of subjects: 45
Study 29488274 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic electroacupuncture
Number of subjects: 200
Study 29488274 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 200
Study 28111123 — intervention group
Group type: EXPERIMENTAL
Intervention: Broaching
Number of subjects: 42
Study 28111123 — intervention group
Group type: COMPARATOR
Intervention: Compaction
Number of subjects: 42
Study 24671434 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (10 dance classes in 5 weeks in addition to counselling)
Number of subjects: 40
Study 24671434 — intervention group
Group type: COMPARATOR
Intervention: Control (no dance, standard of care, counselling)
Number of subjects: 40
Study 23530946 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%-timolol 0.5% (D/T)
Number of subjects: 21
Study 23530946 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%-timolol 0.5% (B/T)
Number of subjects: 21
Study 23530946 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 21
Study 20558416 — intervention group
Group type: EXPERIMENTAL
Intervention: Indometacin (100-200 mg intramuscularly or orally)
Number of subjects: 39
Study 20558416 — intervention group
Group type: EXPERIMENTAL
Intervention: Indometacin (oral or intramuscular)
Number of subjects: 39
Study 18216286 — intervention group
Group type: EXPERIMENTAL
Intervention: CGRP(8‐37) (1200 ng . min(‐1) . dl(‐1) forearm)
Number of subjects: 22
Study 18216286 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (5 mug . min(‐1) . dl(‐1) forearm)
Number of subjects: 22
Study 18216286 — intervention group
Group type: COMPARATOR
Intervention: l‐NMMA (0.2 mg . min(‐1) dl(‐1) forearm)
Number of subjects: 22
Study 18216286 — intervention group
Group type: COMPARATOR
Intervention: Aprepitant (375 mg orally)
Number of subjects: 22
Study 18216286 — intervention group
Group type: COMPARATOR
Intervention: Time of assessment
Number of subjects: 22
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% NaOCl for 120 s
Number of subjects: 40
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% NaOCl for 30 s
Number of subjects: 40
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% NaOCl for 60 s
Number of subjects: 40
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% NaOCl for 120 s
Number of subjects: 40
Study 16310920 — intervention group
Group type: COMPARATOR
Intervention: Control (without AE and NaOCl)
Number of subjects: 40
Study 16310920 — intervention group
Group type: COMPARATOR
Intervention: Only AE
Number of subjects: 40
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% NaOCl for 30 s
Number of subjects: 40
Study 16310920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% NaOCl for 60 s
Number of subjects: 40
Study 12690270 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 455
Study 12690270 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil
Number of subjects: 455
Study 11060831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 4024
Study 8624086 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory drugs
Number of subjects: 0
Study 8157776 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR)
Number of subjects: 8
Study 8157776 — intervention group
Group type: COMPARATOR
Intervention: Coronally positioned flap (CPF)
Number of subjects: 8
Study 8157776 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic assessment (GTR)
Number of subjects: 8
Study 8157776 — intervention group
Group type: COMPARATOR
Intervention: Radiographic assessment (CPF)
Number of subjects: 8
Study 3262320 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg/kg
Number of subjects: 120
Study 3262320 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 5 mg/kg
Number of subjects: 120
Study 31013466 — intervention group
Group type: EXPERIMENTAL
Intervention: T-CBT with letters
Number of subjects: 59
Study 31013466 — intervention group
Group type: COMPARATOR
Intervention: T-CBT without letters
Number of subjects: 59
Study 31013466 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sample (both groups)
Number of subjects: 59
Study 29940209 — intervention group
Group type: EXPERIMENTAL
Intervention: PREPARE + AD
Number of subjects: 0
Study 29940209 — intervention group
Group type: COMPARATOR
Intervention: AD-only
Number of subjects: 0
Study 28914131 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA injections (maximum total dose per injection cycle: 30 U/kg or 1000U) into the gastrocnemius-soleus complex and other muscles as required.
Number of subjects: 207
Study 26030111 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation challenges with terpenes and terpenoids
Number of subjects: 45
Study 26030111 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal challenges with volatile organic compounds (VOCs) including terpenes and terpenoids
Number of subjects: 45
Study 26030111 — intervention group
Group type: COMPARATOR
Intervention: Inhaled challenges
Number of subjects: 45
Study 26030111 — intervention group
Group type: COMPARATOR
Intervention: Intradermal challenges
Number of subjects: 45
Study 23337413 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide anesthesia
Number of subjects: 5133
Study 21388456 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral retinoids (dosages between 10 and 25 mg, with stepwise escalation)
Number of subjects: 44
Study 21388456 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinoids as single agent therapy
Number of subjects: 44
Study 21388456 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinoids combined with phototherapy
Number of subjects: 44
Study 21388456 — intervention group
Group type: COMPARATOR
Intervention: Retinoids
Number of subjects: 44
Study 17544212 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week mindfulness-based meditation program
Number of subjects: 37
Study 17544212 — intervention group
Group type: COMPARATOR
Intervention: wait-list control group
Number of subjects: 37
Study 16867088 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block with bupivacaine
Number of subjects: 52
Study 16867088 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 52
Study 14644692 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of CONSORT guidelines in behavioral medicine research
Number of subjects: 0
Study 14644692 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral medicine-specific guidelines (e.g., treatment adherence)
Number of subjects: 0
Study 10856098 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX) 50 mg/m² IV on day 1 and Vinorelbine (VNB) 25 mg/m² IV on days 1 and 8 (arm 1)
Number of subjects: 300
Study 10856098 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX) 70 mg/m² IV on day 1 (arm 2)
Number of subjects: 300
Study 10856098 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX) 40 mg/m² IV on day 1 and Vinorelbine (VNB) 20 mg/m² IV on days 1 and 8 (arm 1) after dose reduction
Number of subjects: 300
Study 10856098 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX) 60 mg/m² IV on day 1 (arm 2) after dose reduction
Number of subjects: 300
Study 10856098 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 300
Study 7474314 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg suppository just after induction of anesthesia (Group T)
Number of subjects: 36
Study 7474314 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg suppository about 90 min before incision (Group P)
Number of subjects: 36
Study 7474314 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 36
Study 2318223 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 60 mg
Number of subjects: 20
Study 2318223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6985835 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy (C. parvum 4 mg subcutaneously weekly, along with chemotherapy)
Number of subjects: 181
Study 6985835 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (vincristine, Daunorubicin, prednisone, Cytosine Arabinoside, and 6-mercaptopurine)
Number of subjects: 181
Study 6985835 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (13 mg/m2)
Number of subjects: 181
Study 31659963 — intervention group
Group type: EXPERIMENTAL
Intervention: Two cannulated screws fixation
Number of subjects: 120
Study 31659963 — intervention group
Group type: COMPARATOR
Intervention: Three cannulated screws fixation
Number of subjects: 120
Study 28759347 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT) after breast conservation surgery
Number of subjects: 1003
Study 25265544 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134
Study 25265544 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134
Study 24330473 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile Massage (TM)
Number of subjects: 45
Study 24330473 — intervention group
Group type: COMPARATOR
Intervention: Rest to Music (RTM)
Number of subjects: 45
Study 21270442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lestaurtinib (80 mg twice daily)
Number of subjects: 224
Study 21270442 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 224
Study 19581801 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboelastometry (EXTEM and FIBTEM tests) in patients with overt DIC
Number of subjects: 28
Study 19581801 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboelastometry (EXTEM and FIBTEM tests) in patients without DIC
Number of subjects: 28
Study 19581801 — intervention group
Group type: COMPARATOR
Intervention: Traditional coagulation assays
Number of subjects: 28
Study 19581801 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic curves for MCF, CFT, and alpha angle
Number of subjects: 28
Study 17132720 — intervention group
Group type: EXPERIMENTAL
Intervention: I-CHOP
Number of subjects: 477
Study 17132720 — intervention group
Group type: COMPARATOR
Intervention: Standard CHOP
Number of subjects: 477
Study 15529604 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 60
Study 15529604 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day + ranitidine 150 mg/day
Number of subjects: 60
Study 15529604 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day + 30 g alcohol/day
Number of subjects: 60
Study 11369146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative education
Number of subjects: 10
Study 11369146 — intervention group
Group type: COMPARATOR
Intervention: Control (no pre-operative education)
Number of subjects: 10
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: CSA-based immunosuppression
Number of subjects: 137
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506-based immunosuppression
Number of subjects: 137
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion from CsA to FK506
Number of subjects: 137
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion from FK506 to CsA
Number of subjects: 137
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 treatment
Number of subjects: 137
Study 9664981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 137
Study 7622343 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol (12 gm daily)
Number of subjects: 28
Study 7622343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 7622343 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol
Number of subjects: 28
Study 2513858 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural clonidine 150 micrograms
Number of subjects: 20
Study 2513858 — intervention group
Group type: COMPARATOR
Intervention: Morphine 4 mg
Number of subjects: 20
Study 2513858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 1198939 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses to simple step stimuli
Number of subjects: 10
Study 1198939 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses to pulse step stimuli
Number of subjects: 10
Study 30681726 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver/Spleen Stiffness Measurement (LSSM) arm (n = 274)
Number of subjects: 548
Study 30681726 — intervention group
Group type: COMPARATOR
Intervention: Conventional arm (n = 274)
Number of subjects: 548
Study 30681726 — intervention group
Group type: EXPERIMENTAL
Intervention: LSSM arm
Number of subjects: 548
Study 30681726 — intervention group
Group type: COMPARATOR
Intervention: Conventional arm
Number of subjects: 548
Study 29949273 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm normal saline distention solution (0.9% normal saline warmed up to 36⁰C)
Number of subjects: 100
Study 29949273 — intervention group
Group type: COMPARATOR
Intervention: Room temperature normal saline solution (0.9% normal saline at 25⁰C)
Number of subjects: 100
Study 25934173 — intervention group
Group type: EXPERIMENTAL
Intervention: PARO therapy group
Number of subjects: 40
Study 25934173 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial activities control group
Number of subjects: 40
Study 25934173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 23287505 — intervention group
Group type: EXPERIMENTAL
Intervention: Subharmonic imaging (SHI)
Number of subjects: 2
Study 23287505 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopband (SB) filter
Number of subjects: 2
Study 23287505 — intervention group
Group type: COMPARATOR
Intervention: Fundamental mode
Number of subjects: 2
Study 21596257 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap-off epi-LASIK with mitomycin-C (MMC)
Number of subjects: 48
Study 21596257 — intervention group
Group type: COMPARATOR
Intervention: Flap-on epi-LASIK with mitomycin-C (MMC)
Number of subjects: 48
Study 21596257 — intervention group
Group type: COMPARATOR
Intervention: Flap-on and flap-off epi-LASIK with mitomycin-C (MMC)
Number of subjects: 48
Study 19307815 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 19307815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16784467 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge protocol
Number of subjects: 60
Study 16784467 — intervention group
Group type: COMPARATOR
Intervention: Bridge-less protocol
Number of subjects: 60
Study 16281463 — intervention group
Group type: EXPERIMENTAL
Intervention: Data Monitoring Committees (DMCs)
Number of subjects: 100
Study 16281463 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 100
Study 10674280 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo substitution during interruption of paroxetine
Number of subjects: 0